Overview
Polares Medical, a clinical-stage structural heart company based in Lausanne, Switzerland, has raised $50 million in a Series C funding round led by DC Global Ventures and Lumination Partners. The funds will be used to expand operations and advance research on the MRACE posterior leaflet replacement system, a transcatheter therapy aimed at treating mitral regurgitation. With over 70 patients in clinical trials showing promising one-year data, the company aims to enhance treatment options for this condition.
Products
Loading...
Recent Deals
Investors: DC Global Ventures, Lumination Partners
Polares Medical, a clinical-stage structural heart company based in Lausanne, Switzerland, has raised $50 million in a Series C funding round led by DC Global Ventures and Lumination Partners. The funds will be used to expand operations and advance research on the MRACE posterior leaflet replacement system, a transcatheter therapy aimed at treating mitral regurgitation. With over 70 patients in clinical trials showing promising one-year data, the company aims to enhance treatment options for this condition.